PET-CT Scanner Device continues to witness a high adoption rate with typical applications in cancer diagnosis and research

PET-CT scanner device is one of the most innovative diagnostic tools. This tool enables radiologists to obtain a comprehensive diagnosis by viewing a digital image of the affected tissue in a matter of seconds. The diagnostic tool can be used to generate a prediction period by comparing the parameters derived from the images with known images of the same or similar type of tissue in various parts of the body. The process is very convenient as it is possible to conduct the test in the patient's home and obtain a confirmed diagnosis much faster. It also saves the radiology professional the hassle of traveling to the patient's home to perform the test.

PET-CT Scanners are not limited to oncology imaging. The PET-CT scanner has enabled medical experts to create detailed images of the brain, heart, and even bones in a human being. One of the major breakthroughs made in this field was the discovery of positron-emitting radiotherapy. PETS can also be applied in other areas such as neurology, ophthalmology, cardiology, gastroenterology, and even oncology imaging. The PET-CT technology is utilized in many different domains of health care. One such application is nuclear medicine imaging. This technology has enabled nuclear medicine specialists to produce detailed pictures of the internal organs of patients using PET scans. Nuclear medicine specialists use these scans to study patients with cancer, Parkinson's disease, diabetes, multiple sclerosis, head injuries, and brain tumors.

PETS can also be used to study patients undergoing clinical trials. These scans provide important medical information that can be crucial in making important decisions for patients undergoing medical treatments. With millions of diagnostic scans already completed worldwide, the global PET-CT scanner device market is growing at an exponential rate. Many of the diagnostic PETS devices are designed to yield detailed images of the human body and are capable of generating high-quality images at lower energy consumption. Recently, in March 2021, Siemens Healthineers received the U.S. Food and Drug Administration (FDA) clearance for its Biograph Vision Quadra, a PET-CT scanner for clinical use and translational research.